Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Farquharson currently holds 101,276 shares of Rani Therapeutics Holdings, Inc. (RANI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Farquharson has been a net seller of RANI stock. They have purchased $0 and sold $853.7K worth of shares.
Andrew Farquharson's most recent insider trade was on Dec 16, 2024, when they sold 101,276 shares at $0.00 per share.
Andrew Farquharson serves as Executive at Rani Therapeutics Holdings, Inc. (RANI). They have executed 12 insider transactions totaling $853.7K over their tenure at the company.
Andrew Farquharson holds the position of Executive at Rani Therapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Andrew Farquharson has shown a selling trading pattern, with $0 in total purchases and $853.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew Farquharson was on Aug 17, 2022, when they sold $746.7K worth of RANI shares. This transaction involved 71,042 shares at $10.51 per share.
Andrew Farquharson currently owns 101,276 shares of Rani Therapeutics Holdings, Inc. (RANI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Farquharson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Farquharson has 12 Form 4 filings on record as an insider at Rani Therapeutics Holdings, Inc..
Set alerts for Andrew Farquharson and 40,000+ other insiders.